Literature DB >> 656265

Comparison of plasma and saliva levels of metoprolol and oxprenolol.

C P Dawes, M J Kendall, V A John.   

Abstract

1 Plasma and saliva levels of metoprolol and oxprenolol have been compared in two groups of healthy volunteers. 2 Mean salivary oxprenolol levels were lower than, but closely related to the corresponding plasma levels (r=0.93), the mean ratio of saliva:plasma concentration being 0.42. 3 Mean salivary metoprolol concentrations were considerably greater thatn the corresponding plasma levels and the relationship between the concentrations in the two fluids was less clear. 4 The evidence presented suggests that oxprenolol diffuses passively whilst metoprolol is actively secreted into saliva. The mechanism involved in the active process is not known.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656265      PMCID: PMC1429277          DOI: 10.1111/j.1365-2125.1978.tb01627.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.

Authors:  P H Degen; W Riess
Journal:  J Chromatogr       Date:  1976-06-09

2.  The permeability of the human parotid gland to a series of sulfonamide compounds, para-aminohippurate and inulin.

Authors:  S A KILLMANN; J H THAYSEN
Journal:  Scand J Clin Lab Invest       Date:  1955       Impact factor: 1.713

3.  Nitrogenous substances in saliva. 2. Urea and rhodan.

Authors:  Y ARAKI
Journal:  Jpn J Physiol       Date:  1952-07

4.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

5.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  Relationship between theophylline concentration in plasma and saliva of man.

Authors:  R Koysooko; E F Ellis; G Levy
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

7.  The excretion of drugs in saliva. Antibiotics.

Authors:  J F Borzelleca; H M Cherrick
Journal:  J Oral Ther Pharmacol       Date:  1965-11

8.  Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins.

Authors:  K A Johansson; C Appelgren; K O Borg; R Elofsson
Journal:  Acta Pharm Suec       Date:  1974-09

9.  Application of salivary salicylate data to biopharmaceutical studies of salicylates.

Authors:  G Graham; M Rowland
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

10.  Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man.

Authors:  L Brunner; P Imhof; D Jack
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

View more
  5 in total

1.  Salivary concentrations of pirmenol as a possible cause of unpleasant taste.

Authors:  B F Johnson; V Shekar; T Woodman; A T Canada
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

2.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

3.  Acebutolol saliva excretion.

Authors:  J F Giudicelli; J L Freslon; C Richer
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

4.  The basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots.

Authors:  Massimiliano Donzelli; Adrian Derungs; Maria-Giovanna Serratore; Christoph Noppen; Lana Nezic; Stephan Krähenbühl; Manuel Haschke
Journal:  Clin Pharmacokinet       Date:  2014-03       Impact factor: 6.447

5.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.